First Impressions: Industry Leader Kelin Kushin Test Drives Blink Frames

By The Blink Team

At Globe Biomedical, we talk a lot about 'vision technology made invisible,' but nothing beats seeing industry experts experience it firsthand. We recently sent a beta unit of our Blink Frames to Kelin Kushin, the Chief Growth Officer at Vivid Vision, and her reaction encapsulates exactly why we built this platform.

Kelin Kushin wearing Blink smart frames and showing the packaging — Kelin Kushin: 'Blink checks all the boxes!'

In her recent update, Kelin highlighted the key differentiator that sets Blink apart from other smart eyewear on the market. Unlike traditional smart glasses that look outward at the world, our patented sensor array is eye-facing. This allows the frames to continuously monitor the eye itself in real-time.

As Kelin noted, this shift in perspective allows researchers and clinicians to monitor critical risk factors that were previously impossible to track outside the clinic. Currently, for our pediatric myopia management focus, this means objectively tracking:

Screen time vs. Outdoor time
Lens wear compliance
Blink rates
Activity levels

Beyond our current FDA Class II clearance for myopia and amblyopia management, the industry is buzzing about what comes next. Kelin expressed excitement about the 'pipeline of future features' and the potential for new ocular biomarkers. While we are currently focused on pediatric eye health, the architecture of Blink Frames is designed to eventually support research into broader areas, aiming to help unlock mysteries around conditions like dry eye and glaucoma in the future.

We are grateful to have passionate visionaries like Kelin as advisors as we move from 'hype' to tangible health outcomes. As she put it, 'The ability to monitor these things reliably and consistently after the patient leaves the clinic is truly exciting.